A practical reference on research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-11 and is reviewed periodically as new material appears.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
The word bacteria ( ; sing.: bacterium) is the plural of the Neo-Latin bacterium, which is the romanisation of the Ancient Greek βακτήριον (baktḗrion), the diminutive of βακτηρία (baktēría), meaning 'staff' or 'cane', because the first ones to be discovered were rod-shaped. The word was first used to refer to bacteria in 1828.
=== Stationary compound selection === The polarity of the solute is crucial for the choice of stationary compound, which in an optimal case would have a similar polarity as the solute. Common stationary phases in open tubular columns are cyanopropylphenyl dimethyl polysiloxane, carbowax polyethyleneglycol, biscyanopropyl cyanopropylphenyl polysiloxane and diphenyl dimethyl polysiloxane. For packed columns more options are available.
== Applications == This chemical similarity can be exploited in cancer, where a protein may mutate into an "always on" (constitutively active) state. A mutation may occur to replace a tyrosine (which needs to be phosphorylated in order to activate the protein) with an aspartic acid (which would not need to be phosphorylated). In a laboratory setting, the use of recombinant proteins to artificially introduce phosphomimetics is a common tool for studying phosphorylation and protein activation. For example, the IRF3 protein must be phosphorylated for its normal activity (transcription of its target genes, like IFNβ), but when serine amino acid residues were mutated to aspartic acid, the activity increased 90-fold. Phosphomimetics are commonly used in a gain of function experiment with respect to phosphorylation. For example, aspartate mutants were successfully used to probe the biological function of the phosphorylation of a threonine residue of a ribosomal protein both in vivo and in vitro to investigate a gain-of-function mutation on a kinase that is related to Parkinson's disease. Phosphomimetics were also used to investigate the therapeutic potential of proteins or peptides. For example, phosphomimetic mutants (using glutamate to mimic serine phosphorylation) have been used to demonstrate that the phosphorylated glycoproteins may have stronger anti-melanoma effects that the wildtype protein.
=== Nuclear magnetic resonance spectroscopy === In NMR spectroscopy, e.g. of the nuclei 1H, 13C and 29Si, frequencies depend on the magnetic field, which is not the same across all experiments. Therefore, frequencies are reported as relative differences to tetramethylsilane (TMS), an internal standard that George Tiers proposed in 1958 and that the International Union of Pure and Applied Chemistry has since endorsed. The relative difference to TMS is called chemical shift. TMS works as an ideal standard because it is relatively inert and its identical methyl protons produce a strong upfield signal, isolated from most other protons. It is soluble in most organic solvents and is removable via distillation due to its low boiling point. In practice, the difference between the signals of common solvents and TMS are known. Therefore, no TMS needs to be added to commercial deuterated solvents, as modern instruments are capable of detecting the small quantities of protonated solvent present. By specifying the lock solvent to be used, modern spectrometers are able to correctly reference the sample; in effect, the solvent itself serves as the internal standard.
Sources: en.wikipedia.org
== Academic and scientific activities == A graduate of Ursinus College, Pennsylvania in 1986, Conway subsequently studied at the Burke Chemical Laboratories of Dartmouth College, New Hampshire, where he obtained his Ph.D. in 1991. His thesis concerned the attempted generation of indolyne (an aromatic compound related to indole). After college, Conway took a postdoctoral appointment in Chicago, later working as a contractor for the Food and Drug Administration, a researcher for Bionetics, a medicinal chemist for Avid Therapeutics (March 1995 – August 1997) and researcher for Message Pharmaceuticals (August 1997 – April 1999). He spent two years in organ distribution at the National Disease Research Interchange, and was subsequently employed by crop protection company Cerexagri as a regulatory chemist from May 2001 to June 2007, when he became a principal chemist for West Pharmaceutical Services. As of July 2013, he was working for a group near Raleigh, North Carolina. Conway has authored eleven professional publications and two patents. One patent covers compounds intended to treat hepatitis B in synergy with lamivudine; another relates to recyclable packaging material. His work has been published in Heterocycles, Synthetic Communications, Organic Preparations and Procedures International, Water Research, Rapid Communications in Mass Spectrometry, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Current Organic Chemistry.
=== Plant breeding === Selective breeding of cannabis plants has expanded and diversified as commercial and therapeutic markets develop. Some growers in the US succeeded in lowering the proportion of CBD-to-THC to accommodate customers who preferred varietals that were more mind-altering due to the higher THC and lower CBD content. In the US, hemp is classified by the federal government as cannabis containing no more than 0.3% THC by dry weight. This classification was established in the 2018 Farm Bill and was refined to include hemp-sourced extracts, cannabinoids, and derivatives in the definition of hemp.
Foster (1895–1970), Manhattan Project chemist and the first female chemist to work for the United States Geological Survey Antoine François, comte de Fourcroy (1775–1809), co-discovered the element Iridium and developed modern chemical notation Joanna Fowler (born 1942), American neural chemist who studied effects on the human brain and radiotracers in brain chemistry Michelle Francl (PhD 1983), American computational chemist known for the 6-31G* basis set for Na to Ar and electrostatic potential charges Edward Frankland (1825–1899), English chemist, one of the originators of organometallic chemistry who introduced the concept of valence Rosalind Franklin (1920–1958), British chemist and crystallographer whose work was central to understanding the molecular structure of DNA Katherine Franz (born 1972), American chemist noted for work in metal ion coordination in biological systems Herman Frasch (1851–1914), German mining engineer and inventor, pioneered the Frasch process Bertram Fraser-Reid (1934–2020), Jamaican synthetic organic chemist who developed the armed-disarmed principle in glycosylation chemistry Helen Murray Free (1923–2021), American chemist who developed self-testing systems for diabetes Carl Remigius Fresenius (1818–1897), German chemist known for work in analytical chemistry Ida Freund (1863–1914), British chemist known for texts on chemistry teaching, andy first woman university chemistry lecturer in the UK Charles Friedel (1832–1899), French chemist, developer of Friedel–Crafts reaction Alexander Naumovich Frumkin (1895–1976), electrochemist and chemist who develped applied electrochemical processes related to chemical sources of electrical power Kenichi Fukui (1918–1998), 1981 Nobel Prize in Chemistry for investigating mechanisms of chemical reactions Elizabeth Fulhame (18th–19th centuries), British chemist, pioneer in the study of catalysis and discoverer of photoreduction Vera Furness (1921–2002), English chemist and industrial manager who worked on the production of the acrylic Courtelle
Pulmonary fibrosis may be a secondary effect of other diseases. Most of these are classified as interstitial lung diseases. Examples include autoimmune disorders, viral infections, and bacterial infections such as tuberculosis that may cause fibrotic changes in the lungs' upper or lower lobes and other microscopic lung injuries. But pulmonary fibrosis can also appear without any known cause. In that case, it is termed "idiopathic". Most idiopathic cases are diagnosed as idiopathic pulmonary fibrosis. This is a diagnosis of exclusion of a characteristic set of histologic/pathologic features known as usual interstitial pneumonia (UIP). In either case, a growing body of evidence points to a genetic predisposition in a subset of patients. For example, a mutation in surfactant protein C (SP-C) has been found in some families with a history of pulmonary fibrosis. Autosomal dominant mutations in the TERC or TERT genes, which encode telomerase, have been identified in about 15% of pulmonary fibrosis patients. Diseases and conditions that may cause pulmonary fibrosis as a secondary effect include:
2 parts bai zhi (Chinese:白芷，Angelica dahurica); 2 parts cao wu (Chinese:草烏，Aconitum sp., monkshood or wolfsbane); 2 parts chuān ban xia (Pinellia ternata); 2 parts chuān xiōng (Ligusticum wallichii, Cnidium rhizome, Cnidium officinale or Szechuan lovage); 2 parts dong quai (Angelica sinensis or female ginseng); 1 part tian nan xing (Arisaema rhizomatum or cobra lily) 8 parts yang jin hua (Datura stramonium, Korean morning glory, thorn apple, jimson weed, devil's trumpet, stinkweed, or locoweed). The active ingredients in tsūsensan are scopolamine, hyoscyamine, atropine, aconitine and angelicotoxin. When consumed in sufficient quantity, tsūsensan produces a state of general anesthesia and skeletal muscle paralysis. Shutei Nakagawa (1773–1850), a close friend of Hanaoka, wrote a small pamphlet titled "Mayaku-ko" ("narcotic powder") in 1796. Although the original manuscript was lost in a fire in 1867, this brochure described the current state of Hanaoka's research on general anesthesia. On 13 October 1804, Hanaoka performed a partial mastectomy for breast cancer on a 60-year-old woman named Kan Aiya, using tsūsensan as a general anaesthetic. This is generally regarded today as the first reliable documentation of an operation to be performed under general anesthesia. Hanaoka went on to perform many operations using tsūsensan, including resection of malignant tumors, extraction of bladder stones, and extremity amputations. Before his death in 1835, Hanaoka performed more than 150 operations for breast cancer.
Sources: en.wikipedia.org
"The meaning of a Beethoven symphony," he wrote, "heard while the listener is walking around or lying in bed is very likely to differ from its effect in a concert hall where people sit as if they were in church." In essays published by the institute's Zeitschrift, Adorno dealt with the atrophy of musical culture that had become instrumental in accelerating tendencies—toward conformism, trivialization, and standardization—already present in the larger culture. Unsurprisingly, Adorno's studies found little resonance among members of the Project. At the end of 1939, when Lazarsfeld submitted a second application for funding, the musical section of the study was left out. Yet during the two years during which he worked on the Project, Adorno was prolific, publishing "The Radio Symphony," "A Social Critique of Radio Music," and "On Popular Music," texts that, along with the draft memorandum and other unpublished writings, are found in Robert Hullot-Kentor's translation, Current of Music. In light of this situation, Horkheimer soon found a permanent post for Adorno at the Institute. In addition to helping with the Zeitschrift, Adorno was expected to be the institute's liaison with Benjamin, who soon passed on to New York the study of Charles Baudelaire he hoped would serve as a model of the larger Arcades Project. In correspondence, the two men discussed the difference in their conceptions of the relationship between critique and artworks that had become manifest through Benjamin's "The Work of Art in the Age of its Technical Reproducibility".
=== Ratings and awards === In 2005 Hibiscus was one of three restaurants to be awarded three-stars by the Egon Ronay Restaurant Guide, along with The Waterside Inn and Restaurant Tom Aikens, and was named Ronay's Restaurant of the Year. The restaurant made its first entry in the World's 50 Best Restaurants in 2010, ranked in 49th place and one of three British restaurants in the list; the following year it moved up to 43rd. The Good Food Guide ranked Hibiscus as the eighth-best restaurant in the UK in its 2013 guide. The restaurant has been given five AA Rosettes by The Automobile Association.
== Diagnosis == Acanthosis nigricans is typically diagnosed clinically based on its characteristic velvety hyperpigmentation and distribution. A skin biopsy is rarely needed but, when performed, shows hyperkeratosis, papillomatosis and mild basal hyperpigmentation. Evaluation aims to identify associated conditions. Investigations may include:
In vacuum applications, a cold trap is a device that condenses all vapors except the permanent gases (hydrogen, oxygen, and nitrogen) into a liquid or solid. The most common objective is to prevent vapors being evacuated from an experiment from entering a vacuum pump where they would condense and contaminate it. Particularly large cold traps are necessary when removing large amounts of liquid as in freeze drying. Cold traps also refer to the application of cooled surfaces or baffles to prevent oil vapours from flowing from a pump and into a chamber. In such a case, a baffle or a section of pipe containing a number of cooled vanes, will be attached to the inlet of an existing pumping system. By cooling the baffle, either with a cryogen such as a dry ice mixture, or by use of an electrically driven Peltier element, oil vapour molecules that strike the baffle vanes will condense and thus be removed from the pumped cavity.
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.